Poster Abstract Session:
136. Clinical Infectious Diseases: Bone and Joint, Skin and Soft Tissue
Friday, October 28, 2016: 12:30 PM-2:00 PM
Room: Poster Hall

Learning Objectives:


Tracks: Pediatric ID, Investigative ID, Adult ID

Sequential Intravenous High Dose Oral Antibiotics in the Treatment of Osteoarticular Infections in Children - A Randomised Controlled Trial
Karen Tsui, MBChB, FRACP ; Haemish Crawford, MBChB, FRACS ; Florina Chan Mow, MBChB ; Rachel Webb, MBChB ; Lesley M. Voss, MB, ChB ; N. Susan Stott, MBChB, FRACS ; Joanna Stewart, MSc ; Diana R. Lennon, MB, ChB
In-Depth Analysis of Oral vs Parenteral Therapy in Pediatric Acute Hematogenous Osteomyelitis
Zaid Alhinai, MD ; Brian Lee, MPH, PhD ; Penelope H. Dennehy, MD, FIDSA, FPIDS ; Michael Koster, MD ; Ian C. Michelow, MD, DTM&H
Clinical Use of Ceftaroline Fosamil for the Treatment of Gram-Positive Osteomyelitis
Leonard B. Johnson, MD, FIDSA ; Jose Vazquez, MD, FACP, FIDSA ; Ananthakrishnan Ramani, MD ; David Guervil, PharmD
Bone and Joint Infections among Hematopoietic Stem cell transplant (HSCT) Recipients 
Cybele Lara Abad, MD ; Vania Phuoc, MD ; Prashant Kapoor, MD ; Aaron Tande, MD ; Irene Sia, MD ; Pritish K. Tosh, MD ; D Osmon, MD
  • Bone and Joint Final ppt .pdf (888.8 kB)
  • Factors for neurologic sequelae in patients with hematogenous vertebral osteomyelitis
    Yu-Mi Lee, MD ; Hyun Jung Park, MD ; Ki-Ho Park, MD ; Oh-Hyun Cho, MD ; Seong Yeon Park, MD ; Chisook Moon, MD ; Sung-Han Kim, MD ; Sang-Oh Lee, MD ; Sang-Ho Choi, MD ; In-Gyu Bae, MD ; Yang Soo Kim, MD ; Jun Hee Woo, MD ; Mi Suk Lee, MD, PhD
    Describing Infections of the Spine treated with Ceftaroline: The DISC Study-preliminary results
    Richard R. Watkins, MD, MS, FACP ; Steven a. Burdette, MD, FIDSA ; Nairmeen Haller, MS/PhD ; Robert A. Bonomo, MD
    Real-World Use ofTelavancin in the Treatment of Osteomyelitis
    Louis Saravolatz, MD, FIDSA ; Cedric W. Spak, MD ; Ali Hassoun, MD FIDSA FACP ; Kerry Cleveland, MD ; Khaled Rikabi, MD, MBA ; Joseph Reilly, PharmD, CGP ; Susan Szpunar, PhD ; Sharon Valenti, MSN, ACNP ; Leonard B. Johnson, MD, FIDSA
    Bone and Joint Infections in Acute Myelogenous Leukemia: A Retrospective Review of Patients at Mayo Clinic
    Vania Phuoc, MD ; Cybele Lara Abad, MD ; Aaron Tande, MD ; Irene Sia, MD ; Pritish K. Tosh, MD ; Prashant Kapoor, MD ; Douglas Osmon, MD
    Clinical Experience Treating Vertebral Osteomyelitis at University of Louisville Hospital
    Julie Harting, PharmD ; Kim Buckner, Program Coordinator ; Francisco Fernandez, MD ; Robert Kelley, PhD ; Paula Peyrani, MD ; Julio Ramirez, MD
    A Rare Case of Septic Arthritis Caused by β-lactamase Producing Neisseria elongata
    Seyed Hosseini, B.S. ; Arthur Winer, MD ; Hannah Park, MD ; Jonathan Chun, MD ; Su Jung Yoo, BS ; Matthew Shou Lun Lee, MD
  • AliKhalessi_Poster.pdf (392.5 kB)
  • Septic Arthritis in ESRD
    Matthew Winn, BS ; Jennifer Waller, PhD ; N Stanley Nahman Jr., MD ; Lu Huber, MD ; Stephanie Baer, MD ; Mufaddal Kheda, MD ; Rhonda Colombo, MD
  • SA Poster for IDSA.pdf (1.7 MB)
  • Culture-Negative Septic Arthritis in Children
    Evangelos Spyridakis, MD ; Laura Anatale-Tardiff, MPH ; Jeffrey S. Gerber, MD, PhD ; Ari B. Frosch, MD Candidate ; Joseph W. St. Geme III, MD, FPIDS ; Eric Porsch, PhD ; Kevin Downes, MD
    Identification of Prosthetic Joint Pathogens Directly in Clinical Specimens by Metagenomic Shotgun Sequencing
    Matthew Thoendel, MD, PhD ; Patricio Jeraldo, PhD ; Kerryl Greenwood-Quaintance, MS ; Janet Yao, PhD ; Matthew Abdel, MD ; Nicholas Chia, PhD ; Robin Patel, MD, FIDSA, D(ABMM) ; Arlen D. Hanssen, MD
    Prosthetic Joint Infection: A Single Center Study Comparing DAIR (Debridement, Antibiotics, Irrigation, and Retention) vs. Exchange Arthroplasty
    Francisco Salgueiro, MD ; Mary Lasalvia, MD, MPH ; Christopher Rowley, MD/MPH ; Adolf Karchmer, MD, FIDSA
  • Salgueiro - ID Week PJI.pdf (422.4 kB)
  • Two-year Outcomes of Infected Total Hip Arthroplasty (THA) Treated With Debridement and Implant Retention
    Andy Miller, MD ; Michael Henry, MD ; Devin Williams, MPH ; Scott Nodzo, MD ; Eileen Finerty, FNP CIC ; Allina Nocon, MPH ; Barry Brause, MD ; Geoffrey Westrich, MD
    Treatment of prosthetic joint infection: DAIR with short duration of rifampicin.
    Henk Scheper, MD ; Daphne Van Hooven, Medical student ; Michiel Van De Sande, MD, PhD ; Stefan De Boer, MD ; Rachid Mahdad, MD ; Martha Van Der Beek, MD, PhD ; Leo Visser, MD PhD ; Mark De Boer, MD PhD ; Rob Nelissen, MD PhD
  • Poster IDSA 2016.pdf (382.7 kB)
  • Decision-Making for Management of Skin and Soft Tissue Infections
    Deepthi Sudhakar, M.D. ; Rahul S. Kamath, B.S. ; Julianna Gardner, B.A. ; Hassan Kamran, M.D. ; Daniel M. Musher, MD
    Economic Burden of Inpatient Stays for Patients with Acute Bacterial Skin and Skin Structure Infections in the United States: A Retrospective Observational Analysis of Premier Hospital Admissions
    Katelyn R. Keyloun, PharmD, MS ; David J. Weber, MD, MPH, FIDSA, FSHEA ; Qi Zhao, MD, MPH ; Michael Ganz, PhD, MS ; Betsey Gardstein, MSPH ; Patrick Gillard, PharmD, MS
    Identification of Patient Characteristics Associated with Rapid Clinical Response in Hospitalized Patients with Skin and Soft Tissue Infections (SSTIs)
    Amy Chang, MD, PharmD ; Jared Borlagdan, Pharmacy student ; Carol Chenoweth, MD, MS, FSHEA, FIDSA ; Tejal Gandhi, MD ; Jerod Nagel, PharmD
    Using the Q Score and Q234 Score to Decrease Unnecessary Pathogen Reporting in Wound Cultures
    April Dyer, PharmD, MBA, MSCR, BCPS ; Elizabeth Dodds Ashley, PharmD, MHS, FCCP, BCPS ; Obiefuna Okoye, MD, MPH
  • Wound Poster final edit.pdf (306.6 kB)
  • Predictors of Mortality following Incident Diabetic Foot Ulcers
    Meghan Brennan, MD ; Timothy Hess, PhD ; Brian Bartle, MPH ; Jennifer Cooper, MPH ; Jonathan Kang, DPM ; Maureen Smith, MD, PhD ; Min-Woong Sohn, PhD ; Christopher Crnich, MD, PhD
    Recurrent Skin and Soft Tissue Infections in Emergency Department Patients in California, 2005-2011
    Larissa May, MD, MSPH ; Eili Klein, PhD ; Loren Miller, MD, MPH ; Elena Martinez, MS, MPH ; Nestor Mojica, MS
    Knowledge, attitudes, and practices associated with the diagnosis and management of skin and soft tissue infections among medical students, residents, and attending physicians.
    Norman Beatty, MD ; Jessica August, MD ; Joe Anthony Saenz, MD ; David Nix, PharmD ; Kathryn Matthias, PharmD ; Mayar Al Mohajer, MD FACP
    Obesity Contributes to Failure of Outpatient Treatment of Skin and Soft Tissue Infections
    Erin Conway, PharmD ; John Sellick, D.O., M.S., FIDSA, FSHEA ; Kari Kurtzhalts, PharmD ; Kari Mergenhagen, Pharm.D., BCPS AQ-ID
    Comparison of Delafloxacin (DLX) and Vancomycin (VAN) by Age and Gender in Two Phase 3 Trials in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs)
    Eric Hansen, MD ; Sergiu Ungureanu, MD ; Borislav Ninov Sr., MD, PhD ; Oscar Pamo Reyna, MD ; Megan Quintas, BS ; Laura Lawrence, B.S. ; Sue K. Cammarata, M.D.
    Evaluation of Digital vs. Manual Measures of Lesion Size in a Phase 3 Trial of Delafloxacin (DLX) in Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
    Michael Jaharis, B.S.c. ; Dipali Patel, M.P.H. ; Laura Lawrence, B.S. ; Megan Quintas, BS ; Carol Tseng, Ph.D. ; Sue K. Cammarata, M.D.
  • Slide1.png (600.7 kB)
  • Epidemiology and risk factors for hospitalization in patients with lower extremity cellulitis: A population-based study
    Jasmine R. Marcelin, MD ; Eugene M. Tan, MD ; Douglas Challener, MD ; Brian Lahr, MS ; Larry M. Baddour, MD, FIDSA
  • epidemiology poster_v4.pdf (1.2 MB)
  • Shewanella algae Infection in United States Naval Special Warfare Trainees
    Kristi Stone-Garza, MD, MPH ; Paul Graf, PhD, D(ABMM) ; Daniel Croom, MD ; Mari Brown, MPH, MS ; Cheryl Andreoli, PhD ; Peter Woodson, MD ; Ryan Maves, MD, FIDSA
    Treatment of Cellulitis in Patients Discharged from the Emergency Room: Appropriateness of Single versus Dual Antimicrobial Therapy.
    Henry Lederer, PharmD ; Yelena Atlasevich, PharmD ; Eva Sullivan, PharmD ; Harminder Sikand, PharmD, FCSHP, FASHP
    Microbiological profile of combat-related extremity wound infections: Trauma Infectious Disease Outcomes Study 2009-2012
    Laveta Stewart, PhD, MSc, MPH ; Faraz Shaikh, MS ; William P. Bradley, MS ; Dan Z. Lu, MS ; Dana M. Blyth, M.D. ; Elizabeth Schnaubelt, MD ; Timothy Whitman, DO ; Margot Krauss, MD, MPH, FACPM ; Lauren Greenberg, MPH ; Katrin Mende, PhD ; David Tribble, MD, DrPH, FIDSA
    In vitro Activity of Ceftaroline Against Skin and Soft Tissue and Respiratory Pathogens Isolated from Latin America
    Douglas Biedenbach, MS ; Meredith Hackel, PhD, MPH ; Joseph Iaconis, PhD ; Dan Sahm, PhD
    Breast infections following mastectomy and reconstruction in breast oncology patients.
    Elizabeth Robilotti, MD MPH ; Christopher Calero, BS ; Jennifer Brite, MPH ; Joseph Disa, MD ; Mini Kamboj, MD
    Comparative-Effectiveness of Ceftaroline and Daptomycin as First-line Therapy for Patients with Skin and Soft Tissue Infections Admitted to Hospitals in the United States Veterans Health Care System
    Rachel S. Britt, PharmD Student ; Grace C. Lee, PharmD, PhD ; Kelly R. Reveles, PharmD, PhD ; Natalie K. Boyd, PharmD, MS ; Kirk E. Evoy, PharmD ; Christopher R. Frei, PharmD, MSc
    Risk Factors Associated with Methicillin-Resistant Staphylococcus aureus (MRSA) Complicated Skin and Soft Tissue Infection (CSSTIs) in Colombia
    Sandra Liliana Valderrama Beltran, MD ; Sandra Gualtero, MD ; Jose Rodriguez, MD ; Johanna Osorio, MD ; Carlos Arturo Alvarez Moreno, Physician infectious diseases ; Fabian Gil, MD ; Carlos Gomez Quintero, MD ; Maria Alejandra Caro, MD ; Sebastian Mackenzie, MD ; Gerson Arias, MD ; Cesar Arias, MD, PhD, FIDSA
    The Telavancin Observational Use Registry (TOUR™): Methodology and Preliminary Clinical Experience
    Adam Bressler, MD ; Ali Hassoun, MD FIDSA FACP ; Christopher Lucasti, DO, FACOI ; Louis Saravolatz, MD, FIDSA ; Dina Besece, PharmD ; Claire Sherman, PhD ; Bibiana Castaneda-Ruiz, MD

    CME Credits: No CME credit is offered for this session.

    ACPE Credits:

    ACPE Number:

    Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.